Latest News
Weather patterns driven by climate change are causing more severe flooding around the globe increasing the risk of potentially life-threatening diarrhea among children under the age of five, particularly among those living in low- and middle-income countries, according to a new study by researchers at the Yale School of Public Health.
- September 25, 2023Source: PLOS Blog
On March 31, 2021, PLOS Computational Biology introduced a new journal requirement: mandated code sharing. The aim was to improve reproducibility and increase understanding of research. At the end of the year-long trial period, code sharing had risen from 53% in 2019 to 87% in 2021. Today, the sharing rate is 96%.
- June 08, 2023
Research studies focused on cancer, climate change, COVID-19, and Medicaid spending took top honors this year at the Yale School of Public Health.
- January 31, 2023
Two members of the Yale Center for Research on Aging (Y-Age) are among three Yale School of Medicine faculty whose work is included on the Clinical Research Forum’s 2023 list of the Top 20 recent research achievements.
- December 15, 2022
Yale School of Public Health Associate Professor Virginia Pitzer, ScD, provides advice for people concerned about holiday gatherings this year given the current multi-pronged threat of COVID-19, flu, and RSV.
- July 19, 2022Source: PolitiFact
Although COVID-19 vaccines are now widely available, reinfections have risen in recent weeks.
- June 30, 2022
Diarrhea is a leading killer of young children around the world, and cases often rise after heavy rains and flooding. But diarrhea risks can also increase in dry conditions, an ominous sign as the world continues to get warmer due to climate change.
- June 20, 2022Source: The New York Times
Most Americans now carry some immune protection, experts said, whether from vaccines, infection or both.
- May 20, 2022Source: Gizmodo
Around 100 cases of the rare, usually hard-to-transmit infection have been found in at least 11 countries.
- January 26, 2022
Delta Variant, Waning Immunity Reduced Pfizer Vaccine’s Effectiveness Against Household Transmission
A new study by Yale School of Public Health researchers suggests that the Pfizer-BioNTech vaccine was more than 91% effective at reducing transmission of coronavirus in Israeli households before the emergence of the delta variant. However, the combined effect of the new variant and waning vaccine-induced immunity considerably reduced the vaccine’s effectiveness against transmission over time.